Dong-A estimated 605.5 BW of sales and 50 BW of ordinary incomes in 2005.

Published: 2006-01-05 06:54:00

Updated: 2006-01-05 06:54:00

Dong-A tentatively reported the sales and ordinary incomes of 2005 at 605 billion won and 50 billion won respectively largely due to the remarkable growth of Styrene and Nicetil.

The company announced to launch the total 12 new prescription drugs for the treatment of cerebral blood flow improv...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK